In Aboriginal ehildren, ehronie suppurative otitis media (CSOM) is a serious heal th problem, partieularly in the remote areas of Australia. Aeeording to the World Health Organization (WHO), CSOM may be seen in more than 34% of ehildren in a given population.' Another possible sequela is a serious intracranial eomplieation. CSOM is a disease of poverty related to poor living conditions, a lack of good water and hygiene, overerowding, early exposure to infection, and poor aecess to medical care-all faetors that appl y to Aboriginal children.? The federal governrnent of Australia recently published national clinical management guidel ines on behalf of the National Aboriginal Community Controlled Organisation (NACCHO) .3
In Aboriginal ehildren, ehronie suppurative otitis media (CSOM) is a serious heal th problem, partieularly in the remote areas of Australia. Aeeording to the World Health Organization (WHO), CSOM may be seen in more than 34% of ehildren in a given population.' Another possible sequela is a serious intracranial eomplieation. CSOM is a disease of poverty related to poor living conditions, a lack of good water and hygiene, overerowding, early exposure to infection, and poor aecess to medical care-all faetors that appl y to Aboriginal children.? The federal governrnent of Australia recently published national clinical management guidel ines on behalf of the National Aboriginal Community Controlled Organisation (NACCHO) . 3 For the past 30 years, the mainstay of treatment for diseh arging ears in the Aboriginal popul ation has been ear toilets or dry ear swabbing followed by administration of antibiotie eardrops. The standard drop s that have been used are made up of 0.5% neomycin B (framyeetin), gramicidin, and dexamethasone. However, this cornbination is potentially ototoxie. Dry ear swabbing has been found to be ineffective," so the current best-practice management entails the use of 0.005 % povidone iodine (a 5% solution of 10% povidone iodine) followed by drying of the external ear eanal with tissue spears and administration of antibiotie eardrops by a tragal pressure injection technique.
Many studies have shown that the nonototoxie quinolones are more effeetive than other ototopicals in the management of CSOM. 4 However, until recently, no eomparison of ototopical therapy had been conducted in Aboriginal children. The reeent NACCHO eardrop trial was the first to do so.
The NACCHO eardrop trial
The NACCHO trial was a co mmunity-based, multicenter, randomized, controlled, double-bl ind study to compare the effieaey of topieal ciprofloxacin/hydroeortisone with that of neomyein B/gramicidin/dexamethasone drop s in the management of CSOM in Abori ginal ehildren. Thi s study was condueted in eight Aboriginal communities located in the northern part s of Western Australia and Queensland. The NACCHO board of direetors reeruited Aboriginal ehildren younger than 15 years who were diagno sed with CSOM (defined by the WHO as otorrhea of more than 2 weeks' duration).
Patients were assigned to receive either topieal 0.3% ciprofloxaein combined with hyd rocortisone or topieal 0.5 % neomycin B combined with gramicidin and dexameth asone. All patients recei ved 5 drops twice dailyfor 9 days. Prior to drop therapy, 0.005 % povidone iodine solution was used as an ear toilet to clear the otorrhea. AIso, data on each patient' s history, epidemiology, and bacteriology with aecompanying video-otoseopie and audiometric findings were obtained at baseline. Aborigi-naI health workers mea sured primary outcomes in term s of the degree of reduction of otorrhea at 10 and 14 day s; seeondary outeomes ineluded eh anges in tympanie membrane perforation status and improvements in hearing. Bacteriology was performed and baeterial resistance studies were eondueted. The results of this study are bein g prep ared for publieation in The Medical Journal ofAu stralia.
In aeeordance with WHO regulations, nonototoxic ototopieal drops in CSOM in Aboriginal children should be the first line of therapy beeause of their efficaey and lack of ototoxicity. Biofilm I recently isolated bacterial biofilm in the middle ear muco sa of an Aboriginal child with CSOM. This finding represents perhaps the first instanee of biofilm being isolated in a normal middle ear structure in achiId. Thi s discovery has important implications forthe development of substances to break down the biofilm' s defen ses and thus allow for subsequent enh ancement of treatment with a quin olone ototopieal agent.
